Skip to main content
Clinicalinfo.HIV.gov logo.
In affiliation with HIV.gov
Main navigation
  • Home
  • About
  • Guidelines
  • Drug Database
  • Glossary
  • News
  • Resources
  • Contact Us
  • English
  1. Home
  2. Guidelines
  3. HIV Clinical Guidelines: Pediatric Opportunistic Infections
  4. Appendix E. Archived Sections

Guidelines for the Prevention and Treatment of Opportunistic Infections in Children With and Exposed to HIV

The information in the brief version is excerpted directly from the full-text guidelines. The brief version is a compilation of the tables and boxed recommendations.

Search Guidelines

  • Perinatal HIV Clinical Guidelines (93)
  • HIV Clinical Guidelines: Pediatric ARV (86)
  • HIV Clinical Guidelines: Adult and Adolescent Opportunistic Infections (64)
  • HIV Clinical Guidelines: Adult and Adolescent ARV (62)
  • HIV Clinical Guidelines: Pediatric Opportunistic Infections (44)
  • Guidelines for Caring for People With HIV Displaced by Disasters (4)
Version:
Brief Full
What's New Introduction Immunizations for Preventable Diseases in Children and Adolescents With HIV Bacterial Infections Candida Infections Coccidioidomycosis COVID-19 Cryptococcosis Cryptosporidiosis Cytomegalovirus Giardiasis Hepatitis B Virus Infection Hepatitis C Virus Infection Herpes Simplex Virus Histoplasmosis Human Papillomavirus Isosporiasis (Cystoisosporiasis) Malaria Microsporidiosis Mpox Mycobacterium avium Complex Disease Mycobacterium tuberculosis Pneumocystis jirovecii Pneumonia Syphilis Toxoplasmosis Varicella-Zoster Virus
Appendix A. Key to Acronyms
Appendix B. Important Guideline Considerations
Appendix C. Panel Members
Appendix D. Financial Disclosures
Overview
Human Herpesvirus 8
Influenza
Progressive Multifocal Leukoencephalopathy
Figure 1. Recommended Immunization Schedule for Children with HIV Infection Aged 0 through 18 Years; United States, 2025
Table 1. Primary Prophylaxis
Table 2. Secondary Prophylaxis
Table 3. Treatment
Table 4. Common Drugs Used for Treatment of Opportunistic Infections in Children With HIV: Preparations and Major Toxicities
Table 5. Significant Drug Interactions for Drugs Used to Treat or Prevent Opportunistic Infections

Download Guidelines

Related Content

  • Clinicalinfo Drug Database
  • HIVinfo Fact Sheets: What Is an Opportunistic Infection?
  • HIVinfo Infographics
  • How to Cite These Guidelines
  • Pediatric Opportunistic Infection Archived Guidelines

Appendices

Appendix E. Archived Sections

Download Guidelines

Related Content

  • Clinicalinfo Drug Database
  • HIVinfo Fact Sheets: What Is an Opportunistic Infection?
  • HIVinfo Infographics
  • How to Cite These Guidelines
  • Pediatric Opportunistic Infection Archived Guidelines

CONNECT WITH US

Footer menu

  • Home
  • About
  • Guidelines
  • Drug Database
  • Glossary
  • News
  • Resources
  • Contact Us
  • Sponsors
  • Nondiscrimination Notice
  • Accessibility
  • Disclaimers
  • Sitemap
  • Privacy Policy
  • HHS Vulnerability Disclosure

External links

  • HIVinfo.NIH.gov
  • HHS.gov
  • NIH.gov
  • Players & Viewers
  • HHS 508
  • HHS Privacy Policy
  • Whitehouse.gov
  • USA.gov
  • Freedom of Information Act

Provided in collaboration with NIH’s Office of AIDS Research.